Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;124(3-4):111-23.
doi: 10.1007/s00508-012-0123-3. Epub 2012 Mar 3.

[Primary Immune Thrombocytopenia in Adults: Diagnostics and Treatment Consensus Statement of the Austrian Society of Hematology and Oncology (ÖGHO)]

[Article in German]
Affiliations

[Primary Immune Thrombocytopenia in Adults: Diagnostics and Treatment Consensus Statement of the Austrian Society of Hematology and Oncology (ÖGHO)]

[Article in German]
Ingrid Pabinger et al. Wien Klin Wochenschr. .

Abstract

Immune Thrombocytopenia (ITP) is a rare and - in most patients - mild disease, but might be associated with severe or even life-threatening bleeding complications. The treatment of ITP has partly changed in recent years, due to new therapeutic options. International guidelines changed accordingly. This consensus statement by the Austrian Society of Hematology and Oncology (OEGHO) is not a new evaluation of the current evidence, but rather tries to discuss the available international guidelines and adapt them to the situation in Austria. The subject is primary ITP in adults only. Classification, epidemiology, clinical presentation and diagnostics of ITP, and especially the management of this disease, are discussed in detail. This includes current aspects of first, second, and third line therapies, splenectomy with its indications and contraindications, and the use of new therapeutic options like thrombopoetin receptor agonists (TRA).

Similar articles

See all similar articles

Cited by 2 articles

References

    1. Med Klin (Munich). 2009 May 15;104(5):372-83 - PubMed
    1. Onkologie. 2010;33 Suppl 3:2-20 - PubMed
    1. Haematologica. 2006 Aug;91(8):1041-5 - PubMed
    1. Blood. 1984 Dec;64(6):1179-83 - PubMed
    1. Nat Med. 2003 Sep;9(9):1123-4 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback